1 asset in Malignant Adrenal Gland Pheochromocytoma
Therapeutic assets addressing Malignant Adrenal Gland Pheochromocytoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Pembrolizumab Malignant Adrenal Gland Pheochromocytoma | M.D. Anderson Cancer Center | P2 | CCC (53) |